l 741626 has been researched along with tyrosine in 1 studies
Studies (l 741626) | Trials (l 741626) | Recent Studies (post-2010) (l 741626) | Studies (tyrosine) | Trials (tyrosine) | Recent Studies (post-2010) (tyrosine) |
---|---|---|---|---|---|
76 | 0 | 33 | 44,273 | 846 | 8,225 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hattori, K; Isosaka, T; Iyo, M; Kohsaka, S; Maekawa, M; Sato, T; Uchino, S; Yagi, T; Yuasa, S | 1 |
1 other study(ies) available for l 741626 and tyrosine
Article | Year |
---|---|
Fyn is required for haloperidol-induced catalepsy in mice.
Topics: Animals; Anti-Dyskinesia Agents; Antipsychotic Agents; Blotting, Western; Calcium; Catalepsy; Cells, Cultured; Dopamine; Genotype; Haloperidol; Immunoblotting; Immunohistochemistry; Immunoprecipitation; In Situ Hybridization; Indoles; Mice; Neurons; Phosphorylation; Piperidines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fyn; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Time Factors; Tyrosine | 2006 |